Author:
Ikoma Takenori,Ohtani Hayato,Ohno Kazuto,Iguchi Keisuke,Suwa Kenichiro,Sawada Michifumi,Tanahashi Yukichi,Sakamoto Atsushi,Saotome Masao,Ichikawa Shintaro,Goshima Satoshi,Maekawa Yuichiro
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging
Reference18 articles.
1. Benson MD, Buxbaum JN, Eisenberg DS, Merlini G, Saraiva MJ, Sekijima Y. Amyloid nomenclature 2018: Recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 2018;25:215‐9.
2. Ruberg FL, Miller EJ. Nuclear tracers for transthyretin cardiac amyloidosis: Time to bone up? Circ Cardiovasc Imaging 2013;6:162‐4.
3. Maurer MS, Schwartz JH, Gundapaneni B, Elliot PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 2018;379:1007‐16.
4. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. Circ Cardiovasc Imaging 2021;14:e000029.
5. Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2021;42:1554‐68.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献